Skip to search formSkip to main contentSkip to account menu

Carbidopa 10 MG / Levodopa 100 MG Oral Tablet [Sinemet]

Known as: Sinemet 10-100 (carbidopa / levodopa) Oral Tablet, Carbidopa 10 MG / L-DOPA 100 MG Oral Tablet [Sinemet], SINEMET 10 MG / 100 MG Oral Tablet 
National Institutes of Health

Related topics

Related topics

12 relations
Aluminum OxideCarbidopaCrospovidoneIndigo Carmine

Broader (1)

Carbidopa 10 MG / Levodopa 100 MG Oral Tablet

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Potential therapeutic effects of antagonizing adenosine A2A receptor, curcumin and niacin in rotenone-induced Parkinson’s disease mice model
Parkinson’s disease (PD) is the second common age-related neurodegenerative disease. It is characterized by control loss of… 
2016
2016
Abuse of Sinemet® (Levodopa/Carbidopa Combination) in a Patient with Schizophrenia -
Sinemet® is a combination of carbidopa and levodopa (L-dopa) that is used to treat Parkinson’s disease and syndrome. L-dopa is… 
Highly Cited
2015
Highly Cited
2015
Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study
See Bezard and Carta for a scientific commentary on this article (doi:10.1093/brain/awu407). In a double-blind placebo-controlled… 
Review
2003
Review
2003
Neuroprotection in Parkinson's disease: Clinical trials
Advances in our understanding of the cause and pathogenesis of Parkinson's disease (PD) have permitted the rational selection of… 
1993
1993
Plasma levels of levodopa and its main metabolites in parkinsonian patients after conventional and controlled-release levodopa-carbidopa associations.
The paper reports plasma levels of levodopa (LD), its main metabolites [dopamine, dihydroxyphenylacetic acid, homovanillic acid… 
1991
1991
Controlled release levodopa/carbidopa (Sinemet CR4) in Parkinson's disease – an open evaluation of efficacy and safety
Abstract Twenty patients with moderately severe Parkinson's disease entered an open study of the efficacy and safety of a slow… 
Highly Cited
1988
Highly Cited
1988
Controlled-release Sinemet (CR-4): a double-blind crossover study in patients with fluctuating Parkinson's disease.
1987
1987
Controlled‐release levodopa/carbidopa.: II. Sinemet CR4 treatment of response fluctuations in Parkinson's disease
Sixteen patients with Parkinson's disease and therapeutic response fluctuations entered an open-label trial of a controlled… 
1987
1987
Parkinson's disease and motor fluctuations
long-acting levodopa/carbidopa combination (CR-CSinemet) was compared with traditional levodopa/carbidopa (Sinemet) open label in… 
Review
1968
Review
1968
Double-blind evaluation of Metoclopramide (MK 745, Sinemet®), Trimethobenzamide (Tigan®), and a placebo as postanaesthetic anti-emetics following Methoxyflurane anaesthesia
Summary and ConclusionsA double-blind comparison of a placebo, metoclopramide, and trimethobenzamide was carried out on 284 adult… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)